The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

General Information

Updated statistics with estimated new cases and deaths for 2009 (cited American Cancer Society as reference 1).

Cellular Classification

Added Mills et al. as reference 3.

Stage IV Papillary and Follicular Thyroid Cancer

Added text to state that oral inhibitors of vascular endothelial growth-factor receptors are under clinical evaluation (cited Sherman et al. as reference 5 and level of evidence 2Dii).

Recurrent Thyroid Cancer

Added text about a phase II study of sorafenib in advanced thyroid cancer (cited Gupta-Abramson et al. as reference 10 and level of evidence 3iiDiii).

Back to Top

< Previous Section  |  Next Section >